Stockreport

Eli Lilly Vs. Amgen: Who Leads Obesity And IMIDs [Seeking Alpha]

Viatris Inc.  (VTRS) 
PDF Moreover, AMGN hopes to grab a piece of the GLP-1s market from LLY. Each of them has advantages, as well as dark spots in the portfolio of drugs relative to the rival [Read more]